. 2023; 20(1): 0-0

Increase of Transforming Growth Factor-B didn't affect Trombospondin1 in preeclampsia placenta

Ani Retno Prijanti1, Nissa Thoyyiba Oktavia3, Febriana Catur Iswanti1, Ninik Mudjihartini1, Yuditiya Purwosunu2
1Department Of Biochemistry And Molecular Biology, and Center of Hypoxia and Oxidative Stress Studies, Faculty Of Medicine, Universitas Indonesia
2Department Of Obstetrics And Gynecology, Faculty Of Medicine-cipto Mangunkusumo Central Hospital, Universitas Indonesia, Jakarta, Indonesia
3Master’s Programe In Biomedical Sciences, Faculty Of Medicine, Universitas Indonesia,`jakarta, Indonesia

Objective: The abnormalities of placental growth process is one of the theories causing preeclampsia. There were antiangiogenic factors that contribute it such as thrombospondin-1 (TSp1) that could stimulate TGF-β, or vice versa. Some researches showed an increase of TGF-β did not figurize it signaling. Therefore, we conduct study to examine the TGF-β signaling proteins through its receptors and TSp1 expression.
Methods: This observational study used 34 normal and 34 preeclampsia placental storaged samples, for examination of TGF-β and TGF-βR 1 and 2, SMAD2 using ELISA, and SMAD2 and TSp1 mRNA using the RT-PCR method. Data were analyzed using SPSS version 20.0, normality test by Kolmogorov-Smirnov, significancy was analyzed using nonparametric Mann-Whitney test, or T test for parametric, with CI 95%. Spearman correlation used for nonparametric data, besides Pearson correlation for parametric data.
Results: Results showed that significant differences between preeclampsia and normal placenta in TGF-β, its receptor, SMAD2, and TSp-1 mRNA. Normal-TGF-β=1.19(0.713-2.051)pg/mg; Preeclampsia-TGFB=2.69(0.906-10.252)pg/mg; p=0.001); Normal-TGFBR1=1.025(0.622-1.402)ng/mg; Preeclampsia-TGFBR1=1.223(0.372-2.553)ng/mg; p=0.004; Normal-TGF-βR2=0.959(0.644-1.634)pg/mg; Preeclampsia-TGFBR2=1.490(0.775-3.645)pg/mg; p=0.0001; Normal-SMAD2= 2.087(1.279-4.300)ng/mg; Preeclampsia-SMAD2=3.508(1.842-22.489)ng/mg; p= 0.0001. The SMAD2 mRNA relative expression (Livax) in normal placenta was=0.71(0.03-7.25); PE=0.49(0.01-40.71); p=0.075), the normal TSp1 mRNA= 1.08(0.09-5.31); PE= 0.21(0.002-24.06); p= 0.002). Correlation test showed strong correlation between TGFB with TGFBR1 and 2 in normal placenta, but no correlation in preeclampsia placenta. No correlation between SMAD2 and TSp1 mRNA in both normal and preeclampsia.
Conclusion: TGF-β signaling in preeclampsia placenta was changed due to the increased of the protein signaling it self without correlation between TGF-β to its receptors and TSp1 relative expression.

Keywords: preeclampsia-placenta, TGF-β,,,, TGF-βRs, SMAD2, Thrombospondin-1


Ani Retno Prijanti, Nissa Thoyyiba Oktavia, Febriana Catur Iswanti, Ninik Mudjihartini, Yuditiya Purwosunu. Increase of Transforming Growth Factor-B didn't affect Trombospondin1 in preeclampsia placenta. . 2023; 20(1): 0-0

Corresponding Author: Ani Retno Prijanti, Indonesia


TOOLS
Print
Download citation
RIS
EndNote
BibTex
Medlars
Procite
Reference Manager
Share with email
Share
Send email to author

Similar articles
Google Scholar